US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 24, 2020 (6 years ago)

Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

What was recalled

Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-4177-73, b) 200 mL bottle when mixed, NDC 0093-4177-74, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.

Recalling firm
Teva Pharmaceuticals USA
NDC code
0093-4177-73
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0013-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Cephalexin recalls

See all